Marconi silence feeds rumors

Article

Rumors are the stuff of celebrity gossip, conspiracy theories, and UFOs. It can be argued that they have no place in healthcare. But the flap over the possible sale of Marconi Medical has laid that hope to rest. DI SCAN has remained mute on the

Rumors are the stuff of celebrity gossip, conspiracy theories, and UFOs. It can be argued that they have no place in healthcare. But the flap over the possible sale of Marconi Medical has laid that hope to rest. DI SCAN has remained mute on the topic since speculation first appeared on the heels of parent company Marconi PLC’s decision in mid-April to move Marconi Medical to its Capital division, which in the past has served as a kind of limbo for parts of the company being readied for sale. Marconi executives have refused comment to DI SCAN. The company has been similarly silent to other media, whose articles on the topic have appeared without statements from Marconi executives.

What Marconi seems not to fully understand is that the media, like nature, abhor a vacuum. Marconi’s silence has led some information outlets to let their imaginations run wild. The result has not always been favorable to Marconi. One well-respected publication described the company’s business as “ailing” and quoted sources that described the company as weakening.

My sources at Marconi and at the company’s suppliers confirm that Marconi Medical is not “ailing” but in fact is having a very good year. The company has focused on its most lucrative offerings, while finding ways to cut R&D costs and extend its range of products within select areas through corporate partnerships. The most recent is the deal with CTI PET Systems to supply PET scanners (see cover story).

Marconi’s strength is not going to be recognized, however, if the company refuses to address the sale issue. Just acknowledging the facts would provide the opportunity for Marconi to put its own spin on the story-to reassure corporate partners and customers. But corporate policy, I’m told, is to say nothing.

Meanwhile Marconi executives get roiled over what they see as misuse of media stories by some of their competitors. They lament that customers are being sent these articles. The nut of the problem, however, may be Marconi’s failure to tell its side of the story. In a world where perception can dictate reality, Marconi is playing a dangerous game, putting at risk equipment sales and critical alliances, as well as key personnel who might seek new employment in light of an uncertain future.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.